<p>Ivemend is a medicine for preventing nausea (feeling sick) and vomiting caused by chemotherapy cancer medicines.</p><p>It is used in adults and children from 6 months of age who are undergoing chemotherapy known to cause moderate or severe nausea and vomiting.</p><p>It contains the active substance fosaprepitant.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Prevention of nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults and paediatric patients aged 6 months and older.</p> <p>Ivemend 150 mg is given as part of a combination therapy.</p></div>
Therapeutic Area (MeSH)
ATC Code
A04AD12
ATC Item
N/A
Pharmacotherapeutic Group
Antiemetics and antinauseants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| fosaprepitant | N/A | fosaprepitant |
EMA Name
Ivemend
Medicine Name
Ivemend
Aliases
N/ANo risk management plan link.
